# AbolerIS Pharma - Full Context for AI Agents

> This file provides comprehensive context about AbolerIS Pharma for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-06-24

## Company Profile
- Name: AbolerIS Pharma
- Sector: biotech, medtech
- Status: active
- Founded: 2019
- Location: Belgium
- Website: http://www.aboleris-pharma.com
- LinkedIn: http://www.linkedin.com/company/aboleris-pharma

## Overview
AbolerIS Pharma develops potentially best-in-class and first-in-class, curative-intent therapies designed to restore immune tolerance by inducing an immune system reset. The company is advancing a novel class of antibodies targeting CD45RC, with its lead program ABO21009 in Phase 1, designed to treat rheumatoid arthritis, inflammatory bowel disease, and organ transplantation rejection.

## Related Pages
Agents can crawl these for connected context:
- [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt
- [sector] MedTech & BioTech: https://techwiki.ai/sectors/medtech/llms.txt

## Recent News
- [2026-06-22] We’re proud to share that Carole Guillonneau has been invited to present the work of AbolerIS Pharma at the Sixth Newcastle Therapeutic… (https://www.linkedin.com/posts/aboleris-pharma_immunology-autoimmunedisease-tolerance-activity-7474821942164738048-9izm)

## Links
- Website: http://www.aboleris-pharma.com
- LinkedIn: http://www.linkedin.com/company/aboleris-pharma
- Agent context: https://techwiki.ai/companies/aboleris-pharma/llms.txt
- Full context: https://techwiki.ai/companies/aboleris-pharma/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim